Chen XY, Li B, Wang Y, Jin J, Yang Y, Huang LH, Yang MD, Zhang J, Wang BY, Shao ZM, Ni T, Huang SL, Hu XC, Tao ZH. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors. Cancer Commun (Lond). 2023 Sep;43(9):1003-1026. doi: 10.1002/cac2.12465. Epub 2023 Jul 11. PMID: 37434394; PMCID: PMC10508140.